Boundless Bio (BOLD) EBT (2023 - 2026)
Boundless Bio (BOLD) posted quarterly EBT of -$81.6 million for Q1 2026, down 414.83% year-over-year from $25.9 million in Q1 2025, and down 455.88% quarter-over-quarter from -$14.7 million in Q4 2025.
Boundless Bio (BOLD) EBT (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported EBT for 4 consecutive years, with -$81.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 414.83% year-over-year to -$81.6 million; the TTM figure through Mar 2026 stood at -$206.3 million (down 196.45% YoY), while the FY2025 annual figure was -$60.8 million, up 10.56% from the prior year.
- EBT retreated to -$81.6 million in Q1 2026 per BOLD's latest filing, from -$14.7 million in the prior quarter.
- Across five years, EBT topped out at -$12.4 million in Q1 2023 and bottomed at -$85.4 million in Q3 2025.
- Historically, EBT has averaged -$29.1 million across 4 years, with a median of -$16.6 million in 2024.
- Annual changes were most pronounced in 2025 — EBT surged 68.49% — and 2026, when it slumped 414.83%.
- Boundless Bio's EBT stood at -$12.9 million in 2023, then plunged by 30.96% to -$16.9 million in 2024, then grew by 12.92% to -$14.7 million in 2025, then slumped by 455.88% to -$81.6 million in 2026.
- Business Quant data shows BOLD's EBT at -$81.6 million in Q1 2026, -$14.7 million in Q4 2025, and -$85.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - | -23.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.43 Mn |
| Mar 31, 2026 | -81.63 Mn |
| Dec 31, 2025 | -14.69 Mn |
| Sep 30, 2025 | -85.43 Mn |
| Jun 30, 2025 | -24.57 Mn |
| Mar 31, 2025 | -15.86 Mn |
| Dec 31, 2024 | -16.86 Mn |
| Sep 30, 2024 | -16.64 Mn |
| Jun 30, 2024 | -20.23 Mn |
| Mar 31, 2024 | -50.32 Mn |
| Dec 31, 2023 | -12.88 Mn |
| Sep 30, 2023 | -13.91 Mn |
| Jun 30, 2023 | -13.11 Mn |
| Mar 31, 2023 | -12.39 Mn |